Bio-Rad Laboratories | BIO - Umsatzerlöse

Aktienkurs
280.12
Täglich Wechseln
4.97 1.81%
Monatlich
0.49%
Jährlich
16.75%
Q2 Prognose
281.68




Der Umsatz Veränderung Datum
Abbott USD 11.16B 300M 2026-03
Agilent USD 1.8B 63M 2025-12
Becton, Dickinson and Co. USD 5.3B 600M 2025-12
Bio Techne USD 295.9M 9.34M 2025-12
Bio-Rad Laboratories USD 592.1M 101.1M 2026-03
Bruker USD 977.2M 116.7M 2025-12
Charles River Laboratories USD 994.2M 5.8M 2025-12
Danaher USD 5.95B 890M 2026-03
General Electric Aerospace USD 11.6B 270M 2026-03
Illumina USD 1.09B 70M 2026-03
IQVIA Holdings USD 4.36B 260M 2025-12
Laboratory Of America USD 3.54B 20M 2026-03
Merck USD 16.29B 110M 2026-03
Mettler Toledo International USD 1.13B 100M 2025-12
Myriad Genetics USD 209.8M 4.1M 2025-12
OraSure Technologies USD 26.76M 322K 2025-12
Pacific Biosciences Of California USD 44.64M 6.2M 2025-12
Quest Diagnostics USD 2.9B 90M 2026-03
Repligen USD 197.91M 8.91M 2025-12
Revvity USD 772.06M 73.06M 2025-12
Roche Holding CHF 15.65B 274.5M 2025-12
Siemens EUR 19.14B 2.29B 2025-12
Standard Biotools USD 23.8M 4.24M 2025-12
Thermo Fisher Scientific USD 11.01B 1.2B 2026-03
Tosoh JPY 256.94B 2.93B 2025-12
Waters USD 932M 132M 2025-12